LBRX
LB Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
6.63 / 10
Outperform
Analyst sentiment is cautiously bullish with a single Strong Buy rating from Stifel, translating to a 100% historical win rate for that analyst. Fund-flow analysis reveals a good overall score of 7.77, driven by a positive medium-scale trend (0.519) despite negative signals in other buckets. This combination suggests that while institutional money is accumulating shares, the lack of broader analyst coverage keeps the overall conviction moderate.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-11
InstitutionStifel
Times predicted2
Historical Win Rate100.0%
What is the market sentiment for LBRX?
- LBRX holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.63/10 (Outperform).
